Press "Enter" to skip to content

BRIEF-Moderna Announces Expansion Of Barda Agreement To…

July 26 – Moderna Inc:

* MODERNA ANNOUNCES EXPANSION OF BARDA AGREEMENT TO SUPPORT LARGER PHASE 3 PROGRAM FOR VACCINE (MRNA-1273) AGAINST COVID-19

* MODERNA-ADDITIONAL FUNDING TO SUPPORT EXPANDED MRNA-1273 CLINICAL DEVELOPMENT PLAN INCLUDING 30,000 PARTICIPANT PHASE 3 COVE STUDY CONDUCTED WITH NIH

* MODERNA-ADDITIONAL FUND OF UP TO $472 MILLION TO SUPPORT PHASE 3 STUDY OF CO´S MRNA VACCINE CANDIDATE AGAINST COVID-19

* THE TOTAL VALUE OF AWARD IS NOW APPROXIMATELY $955 MILLION

* MODERNA – CO REMAINS ON TRACK TO BE ABLE TO DELIVER ABOUT 500 MILLION DOSES PER YEAR, AND POSSIBLY UP TO 1 BILLION DOSES PER YEAR, BEGINNING IN 2021 Source text for Eikon: Further company coverage:

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *